Middle Meningeal Artery Embolization (MMAE) Outcomes for Chronic Subdural Hematoma (cSDH)

NCT06181994 · tracked via the Priya Life Science Canada tracker

Sponsor

Montefiore Medical Center

Phase

Observational

Started

2023-12-05

Last updated

2026-09-21

Condition(s) studied

Chronic Subdural Hematoma

Study summary

This multi-center retrospective cohort study aims to investigate the real-world outcomes of chronic subdural hematoma treated with MMAE, including clinical effectiveness, recurrence rates, and safety profile.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Consecutive adult patients (18 yrs. of age or older) * Endovascular embolization of middle meningeal artery using any embolization material: PVA particles; Onyx, N-butyl cyanoacrylate (nBCA) glue; dimethyl sulfoxide, microcoils, polyvinyl alcohol (PVA) with microcoils Exclusion Criteria: * Endovascular embolization of middle meningeal artery using any other embolization material

Primary outcome measure(s)

Reaccumulation of Hematoma — Within 1 month post MMAE
The percentage of patients who were determined to have a reaccumulation of their hematoma will be tabulated and reported
Rescue surgical evacuation — Between 1-3 months post MMAE
The percentage of patients who were determined to require rescue surgical evacuation of their hematoma will be tabulated and reported

Trial sites (22)

Facility	City	Region	Status
Baptist Health South Florida, Inc.	Coral Gables	Florida	Recruiting
Mayo Clinic Florida	Jacksonville	Florida	Completed
University of Miami	Miami	Florida	Recruiting
Orlando Regional Medical Center	Orlando	Florida	Recruiting
University of Illinois Chicago	Chicago	Illinois	Completed
University of Chicago Medicine	Chicago	Illinois	Recruiting
The University of Iowa	Iowa City	Iowa	Completed
Massachusetts General Hospital	Boston	Massachusetts	Recruiting
Beth Israel Deaconess Medical Center (BIDMC)/Harvard Medical School	Boston	Massachusetts	Recruiting
Lahey Hospital and Medical Center	Burlington	Massachusetts	Recruiting
Allina Health	Minneapolis	Minnesota	Recruiting
Mayo Clinic	Rochester	Minnesota	Completed
Montefiore Medical Center	The Bronx	New York	Recruiting
Geisinger Health	Danville	Pennsylvania	Completed
Thomas Jefferson University	Philadelphia	Pennsylvania	Recruiting
UTHealth Houston	Houston	Texas	Completed
HCA Houston Healthcare Kingwood	Kingwood	Texas	Completed
West Virginia University	Morgantown	West Virginia	Recruiting
Austin Health	Heidelberg	Victoria	Recruiting
Unity Health Toronto	Toronto	Ontario	Completed
University of Toronto	Toronto	Ontario	Recruiting
Toronto Western Hospital	Toronto	Ontario	Completed

More Montefiore Medical Center trials in Canada

Global Multicenter Registry on Transcatheter TRIcuspid Valve RePLACEment Recruiting

International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF) Recruiting

Other trials for the same condition

Management of CSDH With or Without EMMA- a Randomized Control Trial Active, not recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06181994 on ClinicalTrials.gov ↗ ← All trials in Canada